Latest news
Loading news…
Sirna Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring). San Francisco, California, United States Founded 1992 51-100 employees For Profit
Sirna Therapeutics is a biotechnology company exploring the use of RNA interference in human disease therapy.
Sirna Therapeutics was acquired by Merck in 2006 for $1B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
97
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- RNAI
- Exchange
- NASDAQ
- IPO date
- Apr 17, 2003
- Delisted
- Dec 29, 2006
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 8
- Patents granted
- 97
- Trademarks
- 0
- Top patent class
- Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
Company Info
- Founded
- 1992
- Employees
- 51-100
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- News articles
- 31
- HQ
- San Francisco, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
- Exit date
- Apr 17, 2003
- Closed
- Nov 2, 2015
Signals & Scores
- Heat score
- Medium
- Trend (7d)
- 0
- Trend (30d)
- 0
- Trend (90d)
- -0.4
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Sirna Therapeutics
Loading news…
FAQs about Sirna Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.